Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Capital Expenditures (2016 - 2024)

Biomerica's Capital Expenditures history spans 15 years, with the latest figure at $24000.0 for Q2 2024.

  • Quarterly results put Capital Expenditures at $24000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through May 2024 was $51000.0 (down 20.31% YoY), and the annual figure for FY2024 was $51000.0, down 20.31%.
  • Capital Expenditures for Q2 2024 was $24000.0 at Biomerica, up from $6000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $45194.0 in Q1 2021 to a low of $5141.0 in Q3 2021.
  • The 5-year median for Capital Expenditures is $21689.5 (2020), against an average of $20946.3.
  • The sharpest move saw Capital Expenditures skyrocketed 1723.49% in 2020, then crashed 87.01% in 2021.
  • Year by year, Capital Expenditures stood at $21978.0 in 2020, then plummeted by 40.53% to $13071.0 in 2021, then soared by 83.61% to $24000.0 in 2022, then tumbled by 75.0% to $6000.0 in 2023, then surged by 300.0% to $24000.0 in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $24000.0, $6000.0, and $21000.0 for Q2 2024, Q4 2023, and Q3 2023 respectively.